Related Experiment Video
Updated: Jul 4, 2025

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
864
Injury Severity is a Key Contributor to Coagulation Dysregulation and Fibrinogen Consumption
Biorxiv : the Preprint Server for Biology
|January 31, 2024
Summary
Traumatic injury impairs blood clot formation, leading to increased mortality. This study reveals weaker clots and altered coagulation in trauma patients, identifying key predictors of patient outcomes.
Area of Science:
- Trauma and Emergency Medicine
- Hematology
- Biochemistry
Background:
- Traumatic injury is a major cause of death, with hemorrhage accounting for 40% of fatalities in individuals under 45.
- Severe injury and hypoperfusion significantly alter coagulation, hindering stable clot formation and increasing mortality.
Approach:
- Quantified changes in clot formation and mechanics post-trauma using rheological, turbidimetric, and thrombin generation assays.
- Compared coagulation kinetics and mechanics between trauma patients and healthy donors.
- Utilized ELISA to measure fibrinolytic markers: tissue plasminogen activator (tPA) and D-dimer.
Key Points:
- Trauma patients, particularly those with higher Injury Severity Scores (ISS), exhibited reduced clot stiffness, increased fibrinolysis, and diminished thrombin generation compared to healthy controls.
- Fibrinogen concentration, clot stiffness, D-dimer, and tPA levels directly correlated with increasing ISS.
- Machine learning algorithms identified crucial clinical factors influencing patient outcomes.
Conclusions:
- Viscoelastic and biochemical assays reveal significant predictors of mortality in trauma patients.
- Findings support improved patient treatment strategies and the identification of novel therapeutic targets.
Related Concept Videos
Coagulation
6.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.6K
Clot Retraction and Fibrinolysis
6.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.0K
Extrinsic and Intrinsic Pathways of Hemostasis
7.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.7K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
698
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
698
Introduction to Hemostasis
7.8K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.8K
Disorders of Hemostasis
915
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
915

